New research published in Nature Cancer has identified iron accumulation as a trigger for the destruction of CAR-T immune cells. We explore what this unexpected finding could mean for the future of lung cancer treatment.

The EU is consulting on new restrictions on PFAS chemicals, also known as “forever chemicals.” Lung Cancer Europe explains what the proposed regulation involves, why it matters for medicine supply, and how we are engaging with the process.

RET fusions drive around 1 to 2% of all lung cancers. For years, treatment options were limited. That has changed. New data from ASCO 2026 show that targeted therapies now span multiple stages of RET fusion-positive lung cancer, with next-generation options already in development. Lung Cancer Europe explains the science, the treatments, and what to ask your oncologist.